Imazodan

亚马佐旦

Report date: 2022/05/20 16:07:58

Base Information

Drug NameImazodan

Drug Alias Name咪苯嗪酮伊马唑啶伊马佐丹Cl-914

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphodiesterase 3 inhibitors

TargetsPhosphodiesterase 3

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHeart Failure

ATC CodeN/A